EUVIMEDEUVIMED entdecken
Open Access

Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment

Nu N Le iD, Wen Li iD, Lisa J Wilmes, Natsuko Onishi iD, Jessica E Gibbs iD, Deep Hathi, Pouya Metanat iD, Bonnie N Joe iD, John Kornak iD, Dariya Malyarenko, Thomas L Chenevert iD, Patrick Bolan iD und 2 weitere

Radiology: Imaging Cancer · 2026

DOI: 10.1148/rycan.250606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, 2026. Verfasst von Nu N Le und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology & Biomedical Imaging, University of California, 550 16th St, San Francisco, CA 94158. Hauptthemen laut MEDLINE: Breast Neoplasms, Diffusion Magnetic Resonance Imaging, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using an automated apparent diffusion coefficient (ADC) measurement approach, the results of this study demonstrated that early changes in tumor ADC can predict pathologic complete response in participants with breast cancer undergoing neoadjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDiffusion Magnetic Resonance ImagingNeoadjuvant TherapyAdultFemaleHumansMiddle AgedContrast MediaDynamic Contrast Enhanced Magnetic Resonance ImagingPathologic Complete ResponseReproducibility of ResultsRetrospective StudiesTreatment OutcomeClinical Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

BreastDCEDWIDiffusion-weighted ImagingDynamic Contrast-enhancedMR ImagingMR-Diffusion-weighted ImagingMR-Dynamic Contrast-enhancedMRITumor Response

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology & Biomedical Imaging, University of California, 550 16th St, San Francisco, CA 94158.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, Calif.
  • Department of Radiology, University of Michigan, Ann Arbor, Mich.
  • Department of Radiology, University of Minnesota, Minneapolis, Minn.
  • Department of Radiology, University of Washington, Seattle, Wash.

ORCID-Profile: Nu N Le, Wen Li, Natsuko Onishi, Jessica E Gibbs, Pouya Metanat, Bonnie N Joe, John Kornak, Thomas L Chenevert, Patrick Bolan, Savannah C Partridge, Nola M Hylton

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Le, N. N., Li, W., Wilmes, L. J., Onishi, N., Gibbs, J. E., Hathi, D., Metanat, P., Joe, B. N., Kornak, J., Malyarenko, D., Chenevert, T. L., Bolan, P., Partridge, S. C., & Hylton, N. M. (2026). Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.250606

Vancouver

Le NN, Li W, Wilmes LJ, Onishi N, Gibbs JE, Hathi D, et al. Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment. Radiology: Imaging Cancer. 2026. doi:10.1148/rycan.250606

BibTeX
@article{Le2026,
  author = {Le, Nu N and Li, Wen and Wilmes, Lisa J and Onishi, Natsuko and Gibbs, Jessica E and Hathi, Deep and Metanat, Pouya and Joe, Bonnie N and Kornak, John and Malyarenko, Dariya and Chenevert, Thomas L and Bolan, Patrick and Partridge, Savannah C and Hylton, Nola M},
  title = {Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment},
  journal = {Radiology: Imaging Cancer},
  year = {2026},
  doi = {10.1148/rycan.250606}
}
Kostenlos starten →